跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP
Authorized
STANDARD
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP
b. braun medical inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4ae29700c641773b
Company
b. braun medical inc
Type
Standard
Approval Details
Approval Id
4ae29700c641773b
Drug Approval Canada Name
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP
Product Name
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP
Status
Marketed
Status Date
2020-03-25
Original Market Date
2020-03-25
Din
02485699
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
40:12.00
Atc Original
B05XA01 POTASSIUM CHLORIDE
Atc Name
b 05 xa 01
Aig Number
0100273006
Company Name
b. braun medical inc
Company Address
824 Twelfth Avenue, Bethlehem, Pennsylvania, United States, 18018
Active Ingredients
POTASSIUM CHLORIDE
149 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4ae29700c641773b
Type
Standard
Back to Health Canada Approvals